Skip to main content
. 2018 Dec 12;14(1):75–83. doi: 10.1007/s11523-018-0612-z

Fig. 4.

Fig. 4

Time on osimertinib treatment. a All patients who received osimertinib; b patients who received osimertinib following first-line afatinib